FDA warns 2 Indian firms for manufacturing lapses

FDA warns 2 Indian firms for manufacturing lapses

Washington: In its latest action against Indian drug makers, the US health regulator FDA has red- flagged "significant deviations" from good manufacturing practices at two Indian pharmaceutical companies. In the case of Hyderabad-based Posh Chemicals, 

8
Like
Save

Comments

Write a comment

*